Letters
Harm reduction in fight against HIV
Harm reduction interventions should encompass people who inject image and performance enhancing drugs
BMJ 2016; 353 doi: https://doi.org/10.1136/bmj.i1889 (Published 05 April 2016) Cite this as: BMJ 2016;353:i1889
- Jim McVeigh, director1,
- Andreas Kimergård, principal research fellow2,
- Geoff Bates, public health researcher1,
- Vivian D Hope, principal scientist3,
- Fortune Ncube, consultant epidemiologist3
- 1Centre for Public Health, Liverpool John Moores University, Liverpool L3 2ET, UK
- 2Addictions Department, King’s College London, London, UK
- 3National Infection Service, Public Health England, London, UK
- J.McVeigh{at}ljmu.ac.uk
We welcome the news item on the role of harm reduction in the “fight” against HIV,1 and we broadly agree with the findings of the report The Case for a Harm Reduction Decade: Progress, Potential and Paradigm Shifts.2 Clearly harm reduction for people who inject drugs is having a positive impact on HIV in many places around …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£30 / $37 / €33 (excludes VAT)
You can download a PDF version for your personal record.